Cargando…
CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
Although CD133 is a known representative cancer stem cell marker, its function in tumor aggressiveness under hypoxia is not fully known. The aim of this study is to demonstrate that CD133 regulates hypoxia inducible factor (HIF)-1α expression with tumor migration. The CD133(+) pancreatic cancer cell...
Autores principales: | Maeda, Koki, Ding, Qiang, Yoshimitsu, Makoto, Kuwahata, Taisaku, Miyazaki, Yumi, Tsukasa, Koichirou, Hayashi, Tomomi, Shinchi, Hiroyuki, Natsugoe, Shoji, Takao, Sonshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964401/ https://www.ncbi.nlm.nih.gov/pubmed/27367674 http://dx.doi.org/10.3390/ijms17071025 |
Ejemplares similares
-
mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions
por: Matsubara, Shyuichiro, et al.
Publicado: (2013) -
CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
por: Ding, Qiang, et al.
Publicado: (2014) -
Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
por: Miyazaki, Yumi, et al.
Publicado: (2016) -
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
por: Maeda, S, et al.
Publicado: (2008) -
Pancreaticogastrostomy: a pancreas-transfixing method with duct-to-mucosa anastomosis (with video)
por: Takao, Sonshin, et al.
Publicado: (2011)